Related Experiment Video
Updated: Jan 21, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
Long non-coding RNA DSCAM-AS1 accelerates the progression of hepatocellular carcinoma via sponging miR-338-3p
Degang Ji1, Guangrui Hu2, Xuanhe Zhang3
1Department of Hepatobiliary Pancreatic Surgery, China-Japan Union Hospital of Jilin University Changchun 130033, Jilin, China.
Abstract:
Aberrant expression of long non-coding RNA DSCAM-AS1 (Down Syndrome Cell Adhesion Molecule antisense) has been observed in several cancers. However, the expression status, biological function and underling mechanism of DSCAM-AS1 in hepatocellular carcinoma (HCC) remain unclear. The expression of DSCAM-AS1 was detected in HCC tissues and serum from both HCC patients and healthy controls. MTS, wound healing and transwell invasion assays were used to examine the effects of DSCAM-AS1 on cell proliferation, migration, and invasion in HCC cells, respectively. MicroRNAs (miRNAs) targeted DSCAM-AS1 was predicated by Starbase2.0 and identified using luciferase reporter and RNA immunoprecipitation assays. The xenograft mice were established to examine the effect DSCAM-AS1 on tumor growth in vivo. We found that DSCAM-AS1 was up-regulated in HCC tissues relative to adjacent non-tumor tissues. Serum levels of DSCAM-AS1 were higher in HCC patients than that in healthy controls. Increased DSCAM-AS1 was associated with poor prognosis. Knockdown of DSCAM-AS1 significantly inhibited HCC cell proliferation, migration and invasion. Moreover, miR-338-3p was confirmed as a direct target of DSCAM-AS1 in HCC cells. The miR-338-3p inhibitor could partially reverse the inhibitory effect of DSCAM-AS1 depletion in HCC cells. DSCAM-AS1 positively regulated CyclinD1 and smoothened (SMO) expression (two targets of miR-338-3p) in HCC cells. Moreover, tumor growth was tremendously retarded in nude mice received injection of SMCC-7721 cells transfected with sh-DSCAM-AS1. Taken together, the present work suggested that DSCAM-AS1 functioned as an oncogenic lncRNA that promoted HCC progression by sponging miR-338-3p.
Insights
Long non-coding RNA DSCAM-AS1 (Down Syndrome Cell Adhesion Molecule antisense) promotes hepatocellular carcinoma (HCC) progression. This oncogenic lncRNA acts as a sponge for miR-338-3p, driving tumor growth and poor prognosis in HCC patients.
Area of Science:
- * Molecular Oncology
- * Cancer Biology
- * RNA Biology
Background:
- * Aberrant expression of long non-coding RNA DSCAM-AS1 (Down Syndrome Cell Adhesion Molecule antisense) is implicated in various cancers.
- * The specific role and regulatory mechanisms of DSCAM-AS1 in hepatocellular carcinoma (HCC) remain largely unelucidated.
Purpose of the Study:
- * To investigate the expression status, biological functions, and underlying molecular mechanisms of DSCAM-AS1 in HCC.
- * To determine the potential of DSCAM-AS1 as a diagnostic biomarker and therapeutic target in HCC.
Main Methods:
- * Quantitative real-time PCR to detect DSCAM-AS1 expression in HCC tissues and serum.
- * In vitro assays (MTS, wound healing, Transwell) to assess proliferation, migration, and invasion of HCC cells.
- * Luciferase reporter and RNA immunoprecipitation assays to validate miRNA targeting.
- * In vivo xenograft mouse models to evaluate the effect of DSCAM-AS1 on tumor growth.
Main Results:
- * DSCAM-AS1 was significantly upregulated in HCC tissues and serum of HCC patients compared to controls, correlating with poor prognosis.
- * Knockdown of DSCAM-AS1 inhibited HCC cell proliferation, migration, and invasion.
- * DSCAM-AS1 directly targets and sponges miR-338-3p, influencing the expression of its targets CyclinD1 and SMO.
- * Depletion of DSCAM-AS1 significantly suppressed tumor growth in vivo.
Conclusions:
- * DSCAM-AS1 acts as an oncogenic long non-coding RNA promoting HCC progression.
- * The DSCAM-AS1/miR-338-3p axis is a key regulatory pathway in HCC development.
- * DSCAM-AS1 represents a potential diagnostic biomarker and therapeutic target for hepatocellular carcinoma.
More Related Videos
08:25Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma
Published on: April 25, 2025
09:27Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish
Published on: April 1, 2021
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
Accelerators
The effectiveness of calcium chloride can...
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Nursing Code of Ethics